Stay updated on Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s displayed software/site revision changed from v3.5.2 to v3.5.3, indicating a site release/version update without altering the study content.
    Difference
    0.1%
    Check dated 2026-04-25T05:22:29.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T00:00:07.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.5.0, replacing Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T01:53:34.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The site revision updated from v3.4.2 to v3.4.3. This appears to be a minor update with no user-facing content changes to the study page.
    Difference
    0.1%
    Check dated 2026-03-12T21:26:04.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Added Amyloidosis topic and a Genetic and Rare Diseases Information Center resource link; page revision updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-12T01:54:15.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1; no changes to the Study Details content or layout were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:34:25.000Z thumbnail image

Stay in the know with updates to Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Therapy for Refractory AL Amyloidosis Clinical Trial page.